EVLO

Evelo Biosciences Stock Price

16.23
-0.12 (-0.73%)
Upgrade to Real-Time
Regular Market
16.23

Low
3.55

52 Week Range

High
19.9283

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Evelo Biosciences Inc EVLO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -0.73% 16.23 13:33:36
Open Price Low Price High Price Close Price Prev Close
16.32 16.23 16.85 16.35
Bid Price Ask Price Spread News
16.03 16.24 0.21 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
529 24,932 $ 16.57 $ 413,096 139,717 3.55 - 19.9283
Last Trade Time Type Quantity Stock Price Currency
13:33:25 1 $ 16.23 USD

Evelo Biosciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 866.26M 53.37M 23.28M $ - $ - -2.42 -7.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 31.38k 0.50%

more financials information »

Evelo Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EVLO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.7016.8513.7915.41124,7181.5310.41%
1 Month11.5116.8510.9713.96130,0174.7241.01%
3 Months12.5716.859.22511.88188,7963.6629.12%
6 Months10.6019.92838.5212.96251,8235.6353.11%
1 Year3.9519.92833.559.81229,95112.28310.89%
3 Years11.3219.92833.019.17118,2834.9143.37%
5 Years16.0019.92833.019.47119,7770.231.44%

Evelo Biosciences Description

Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. Its lead product candidate under development is EDP1815, which is for the treatment of inflammatory diseases and the hyperinflammatory response associated with COVID-19. Other products in the pipeline include EDP1867 and EDP2939 for the treatment of inflammatory disease and EDP1908 for the treatment of cancer.


Your Recent History
NASDAQ
EVLO
Evelo Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.